FDA issues draft guidance for industry on registration and listing of cosmetic product facilities and products Comments can be submitted by September 7th. #MOCRA #cosmetics #FDA #regulation For additional info, please contact [email protected] shorturl.at/AJR14

ToxStrategies LLC is excited to announce that Modality Solutions is joining forces with our firm. toxstrategies.com/2023/08/toxstr…

Marcie Wood and Kirsten Mease are presenting at The Charles River Biotech Symposium and at the preceding workshop on “Better Science with Fewer Animals” on September 10. #toxicology #drugdevelopment #biotech #Biotechnology

ToxStrategies’ scientists have published a manuscript reporting the outcome of a state-of-the-science assessment to develop potential dietary intake limits for hemp-derived cannabidiol (CBD) isolate. The paper appears in the journal Regulatory Toxicology and Pharmacology.

Amy Mihalchik, PhD, DABT, RAC, was recently elected to the Nominating Committee of the American College of Toxicology. The committee develops the annual ballot for ACT elected positions & supports initiatives to identify & foster candidates for leadership opportunities within ACT

ToxStrategies’ Rayetta Henderson is coauthor of two new articles on the preclinical safety of hemp-derived cannabinoids, advancing this emerging field of research and providing support for future studies. The papers appear in the journal Cannabis and Cannabinoid Research. #hemp

EpidStrategies’ scientists are recognized experts in the field of respiratory syncytial virus (RSV). We are presenting two RSV studies at IDWeek on October 11-15, 2023 (epidstrategies.com/publications-c…). Please contact Mina Suh ([email protected]) for more information. #IDWeek

Dr. Naomi Sacks, Vice President of ToxStrategies’ newest division, HEORStrategies, is attending the World Orphan Drug Congress 2023. heorstrategies.com

ToxStrategies’ scientists will participate in The Society of Environmental Toxicology and Chemistry’s (SETAC) 44th Annual Meeting this year on November 12–16, in Louisville, Kentucky. #setaclouisville #setac #toxicology toxstrategies.com/2023/11/toxstr…

Dr. Naomi Sacks, Vice President of ToxStrategies LLC’s newest division, HEORStrategies, is attending ISPOR Europe! HEORStrategies provides research and strategic consulting for US and EU clients. Contact Dr. Sacks ([email protected]) to learn more about HEORStrategies!

ToxStrategies scientists Camarie Perry, Stephanie Vivanco, Ann Holbrow Verwiel, and Deborah Proctor authored a new publication proposing an acute/short-term inhalation guideline for manganese of 5 μg/m3 supported by PBPK modeling. sciencedirect.com/science/articl…

ToxStrategies scientists assessed the risk of human and environmental exposure to PFAS in fluorinated HDPE containers. These analyses indicated no unreasonable non-cancer risk to humans, aquatic species, and terrestrial species. sciencedirect.com/science/articl…

The EPA has begun the process to prioritize five additional chemicals under TSCA. If the EPA determines these chemicals as High Priority Substances, it will begin risk evaluations for them. ToxStrategies stands ready to assist with informing the EPA about these chemicals.

Results from new systematic review of formaldehyde led by ToxStrategies received strong interest as late breaking research presented at the 63rd Annual Meeting of the Society for Toxicology! Thank you ToxStrategies for presenting this important work!

ToxStrategies is presenting research at #AIHAConnect. Mandie Kramer will present an intro to dermal exposure assessments & an intermediate guide to inhalation exposure monitoring. LeeAnn Racz will present a new exposure assessment method for measuring PFCAs from glove fingertips.

ToxStrategies’ scientists will participate in The Society of Environmental Toxicology and Chemistry’s (SETAC’s) 45th Annual Meeting this year on October 20 - 24, in Fort Worth, Texas toxstrategies.com/2024/10/toxstr… #setacfortworth #setac #toxicology

HEORStrategies’ Dr. Naomi Sacks is a co-author on a study of healthcare resource utilization (HRU) for paroxysmal supraventricular tachycardia (PSVT) at #AMCPNexus in Las Vegas, Oct 14-17. The research reveals an urgent need for better outpatient management. #PSVT #AMCPNexus

ToxStrategies LLC congratulates Dr. Harris, Chief Operating Officer and co-founder, on his retirement on December 9. Since 2008, ToxStrategies has grown to encompass a family of companies that solve clients’ most difficult problems. Thanks, Mark, and enjoy your next chapter!

ToxStrategies scientists have published a study that demonstrates using brine from conventional gas wells to deice roads does not pose a significant radiation risk to the public. 🔗 Read more: tandfonline.com/doi/full/10.10…

ToxStrategies scientists have published Handbook of Emergency Response: A Human Factors and Systems Engineering Approach, 2nd Edition. routledge.com/Handbook-of-Em…